sōna
COCCIDIOIDES ANTIBODY Lateral Flow Assay
Coccidioidomycosis (Valley Fever) is difficult to diagnosis due to lack of awareness and symptoms imitating many other respiratory infections.
Valley Fever is said to cause nearly 30% of all community acquired pneumonia (CAP) cases, but only about 20,000 cases are reported each year in the US.1 IMMY’s simple, rapid LFA allows for better care and stewardship for patients.
1) Valley Fever (Coccidiodomycoisis) Statistics. Updated 2022. https://www.cdc.gov/fungal/diseases/coccidioidomycosis/statistics.html

Specimen Types & Registrations
- FDA: Serum & CSF
Product Reference
- CTA2003
Detect Early. Treat Fast. Save Lives.
Features & Benefits

Results in just 30 MINUTES

Highly SENSITIVE & SPECIFIC

Test MORE OFTEN
Clinical relevancy2
Procedure
- DOCUMENTS
- STUDIES
- ORDERING INFORMATION
Coccidioides Antibody LFA
50 tests
Ref: CTA2003
Coccidioides Antibody LFA |
50 tests |
Ref: CTA2003 |
Discover the Life-Saving Potential
Reach out to learn how IMMY’s Coccidioides Antibody Lateral Flow Assay can improve patient health with fast and accurate results.